Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer

Ekkehard Schütz, Mohammad R. Akbari, Julia Beck, Howard B. Urnovitz, William Zhang, Kirsten Bornemann-Kolatzki, William M. Mitchell, Robert K. Nam, Steven A. Narod

Clinical Chemistry · 2014 · 47 citations · 30 references

DOIFull text

Open access

Abstract

Assessment of a limited number of chromosomal structural instabilities by use of massive parallel sequencing of cfDNA was sufficient to distinguish between prostate cancer and controls. This large cohort demonstrates the utility of cfDNA in prostate cancer recently established in other malignant neoplasms.

References

30